Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma

Blank, C.U.; Kelderman, S.; Tinteren, H. van; Heemskerk, B.; Brom, R. van den; Hospers, G.A.; ... ; Larkin, J.M.G. (2013)

Article / Letter to editor

• All authors: Blank, C.U.; Kelderman, S.; Tinteren, H. van; Heemskerk, B.; Brom, R. van den; Hospers, G.A.; Eertwegh, A.J.M. van den; Kapiteijn, E.; Groot, J.W. de; Jansen, R.L.; Fiets, W.E.; Krzystanek, M.; Szallasi, Z.; Furness, A.J.S.; Renn, A.; Gore, M.E.; Lorigan, P.; Schumacher, T.; Haanen, J.B.A.G.; Larkin, J.M.G.
• Date: 2013-05-20
• Journal: Journal of Clinical Oncology
• Volume: 31
• Issue: 15